U.K.-based Axis Spine Technologies closed a $3.1 million (£2.2 million) funding round, Finsmes reported Feb. 24.
ACF Investors' Delta Fund led the round with participation from Mercia's EIS fund. Simon Cartmell also led a solo investment.
Axis Spine Technologies will use the funds to launch devices in the U.S. and further develop its Oblique and Lateral cage implant systems.
The Axis-ALIF received FDA-clearance in May 2020, and the first surgery was completed with the devices in Atlanta in November 2020.
Note: Conversion from pound to USD was current as of Feb. 24.